Finance entity
Every one of those 1 sits in a single category, economy. Bulk drugs and drug intermediates is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Their average consequence score of 5 runs below the beat's 5.4 for that window.
Last mentioned: 4d ago
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, economy. Bulk drugs and drug intermediates is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Their average consequence score of 5 runs below the beat's 5.4 for that window. Source depth averages 2 original sources per story, versus 2.2 across the same-window beat baseline. Namit Joshi appears in 1 tracked Finance story from August 12, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 44 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Namit Joshi. Shared-story counts are live from our verified record — not editorial picks.
India's pharma exports grew 6.8% to $8.1B in Q1 FY27, with the US absorbing $2.5B at a 30.89% share — trade and earnings data that shapes the outlook for Indian healthcare exporters and investors.
Namit Joshi is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
